Current Vascular Pharmacology
Title:Meet Our Editorial Board Member
Volume: 16 Issue: 5
Author(s): Paola Casanello
Affiliation:
Export Options
About this article
Cite this article as:
Casanello Paola , Meet Our Editorial Board Member, Current Vascular Pharmacology 2018; 16 (5) . https://dx.doi.org/10.2174/157016111605180710093331
DOI https://dx.doi.org/10.2174/157016111605180710093331 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Early and Mild Phases of Primary Progressive Aphasia: A Case Series
Current Aging Science Quantitative Analysis of Salicylic Acid and its Derivatives in Primulae radix by High Performance Liquid Chromatography-Diode Array Detection- Electrospray Ionization Mass Spectrometry (HPLC-DAD-ESI-MS) and Simultaneous Determination of Total Polyphenol Content (TPC)
Current Analytical Chemistry Diabetic Cardiovascular Disease – AMP-Activated Protein Kinase (AMPK) as a Therapeutic Target
Cardiovascular & Hematological Agents in Medicinal Chemistry Bone Marrow Microenvironment: A Newly Recognized Target for Diabetes- Induced Cellular Damage
Endocrine, Metabolic & Immune Disorders - Drug Targets The Effect of Stenotic Geometry and Non-newtonian Property of Blood Flow through Arterial Stenosis
Cardiovascular & Hematological Disorders-Drug Targets Contextual Information Acquisition and Management Solutions for IPBased Networks: A Survey
Recent Patents on Telecommunication Micronized Purified Flavonoid Fraction (MPFF)*: A Review of its Pharmacological Effects, Therapeutic Efficacy and Benefits in the Management of Chronic Venous Insufficiency
Current Vascular Pharmacology Editorial: Preeclampsia-Eclampsia, Time to Act and Time to Deepen Research
Current Women`s Health Reviews Overcoming hERG Affinity in the Discovery of Maraviroc; A CCR5 Antagonist for the Treatment of HIV
Current Topics in Medicinal Chemistry IL-1 as a target in inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets TMS - A New Neuroimaging Combinational Tool to Study Brain Function
Current Medical Imaging Biologics in Systemic Sclerosis
Current Pharmaceutical Biotechnology Recent Developments in Computational Prediction of hERG Blockage
Current Topics in Medicinal Chemistry Cytomegalovirus Infections in Non-Immunocompromised and Immunocompromised Patients in the Intensive Care Unit
Infectious Disorders - Drug Targets Post-menopausal Osteoporosis and Probiotics
Current Drug Targets Interactions between Inflammation and Coagulation in Autoimmune and Immune-Mediated Skin Diseases
Current Vascular Pharmacology Infection, its Treatment and the Risk for Stroke
Current Vascular Pharmacology Associative Learning, the Hippocampus, and Nicotine Addiction
Current Drug Abuse Reviews Hypertension, Nitric Oxide, Oxidants, and Dietary Plant Polyphenols
Current Pharmaceutical Biotechnology Risk Stratification in Pulmonary Embolism
Current Respiratory Medicine Reviews